| Using technology to maintain the education of residents during the COVID-19 pandemic RC Chick, GT Clifton, KM Peace, BW Propper, DF Hale, AA Alseidi, ... Journal of surgical education 77 (4), 729-732, 2020 | 1464 | 2020 |
| Results of a randomized phase IIb trial of nelipepimut-S+ trastuzumab versus trastuzumab to prevent recurrences in patients with high-risk HER2 low-expressing breast cancer GT Clifton, D Hale, TJ Vreeland, AT Hickerson, JK Litton, G Alatrash, ... Clinical Cancer Research 26 (11), 2515-2523, 2020 | 79 | 2020 |
| Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence TA Brown, EA Mittendorf, DF Hale, JW Myers, KM Peace, DO Jackson, ... Breast Cancer Research and Treatment 181 (2), 391-401, 2020 | 51 | 2020 |
| Chemoprevention in familial adenomatous polyposis: past, present and future PM Kemp Bohan, G Mankaney, TJ Vreeland, RC Chick, DF Hale, ... Familial cancer 20, 23-33, 2021 | 46 | 2021 |
| Educating surgical oncology providers on perioperative opioid use: results of a departmental survey on perceptions of opioid needs and prescribing habits HA Lillemoe, TE Newhook, TJ Vreeland, EM Arvide, WL Dewhurst, ... Annals of surgical oncology 26, 2011-2018, 2019 | 40 | 2019 |
| A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2 JM Greene, EJ Schneble, DO Jackson, DF Hale, TJ Vreeland, M Flores, ... Cancer Immunology, Immunotherapy 65, 383-392, 2016 | 36 | 2016 |
| Cancer vaccines: should we be targeting patients with less aggressive disease? DF Hale, GT Clifton, AK Sears, TJ Vreeland, N Shumway, GE Peoples, ... Expert review of vaccines 11 (6), 721-731, 2012 | 34 | 2012 |
| Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions J Berry, T Vreeland, A Trappey, D Hale, K Peace, J Tyler, A Walker, ... Expert review of clinical immunology 13 (3), 235-245, 2017 | 32 | 2017 |
| Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge TE Newhook, EA Vega, TJ Vreeland, L Prakash, WL Dewhurst, ML Bruno, ... Surgery 167 (2), 442-447, 2020 | 31 | 2020 |
| Prognosis associated with CA19-9 response dynamics and normalization during neoadjuvant therapy in resected pancreatic adenocarcinoma TE Newhook, TJ Vreeland, JF Griffin, RSS Tidwell, LR Prakash, EJ Koay, ... Annals of surgery 277 (3), 484-490, 2023 | 30 | 2023 |
| Benefit of gemcitabine/nab-paclitaxel rescue of patients with borderline resectable or locally advanced pancreatic adenocarcinoma after early failure of FOLFIRINOX TJ Vreeland, F McAllister, S Javadi, LR Prakash, DR Fogelman, L Ho, ... Pancreas 48 (6), 837-843, 2019 | 30 | 2019 |
| Prospective study of perioperative circulating tumor DNA dynamics in patients undergoing hepatectomy for colorectal liver metastases TE Newhook, MJ Overman, YS Chun, A Dasari, CWD Tzeng, HST Cao, ... Annals of surgery 277 (5), 813-820, 2023 | 29 | 2023 |
| Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast … RC Chick, GT Clifton, DF Hale, TJ Vreeland, AT Hickerson, PMK Bohan, ... Clinical Immunology 225, 108679, 2021 | 29 | 2021 |
| The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients AA Jácome, TJ Vreeland, B Johnson, Y Kawaguchi, SH Wei, Y Nancy You, ... British journal of cancer 124 (4), 797-804, 2021 | 29 | 2021 |
| Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer CJ Allen, TE Newhook, TJ Vreeland, P Das, BD Minsky, M Blum, S Song, ... Journal of surgical oncology 120 (8), 1350-1357, 2019 | 29 | 2019 |
| Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines TJ Vreeland, GT Clifton, GS Herbert, DF Hale, DO Jackson, JS Berry, ... Expert Review of Clinical Immunology 12 (12), 1347-1357, 2016 | 29 | 2016 |
| Analysis of clinical and pathologic factors of pure, flat epithelial atypia on core needle biopsy to aid in the decision of excision or observation JS Berry, AF Trappey, TJ Vreeland, AR Pattyn, GT Clifton, EA Berry, ... Journal of Cancer 7 (1), 1, 2016 | 28 | 2016 |
| Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients TA Brown, K Byrd, TJ Vreeland, GT Clifton, DO Jackson, DF Hale, ... Cancer medicine 8 (10), 4678-4687, 2019 | 27 | 2019 |
| American College of Surgeons Commission on Cancer standard for curative-intent pulmonary resection AP Nissen, TJ Vreeland, M Teshome, MA Archer, AB Francescatti, ... The Annals of Thoracic Surgery 113 (1), 5-8, 2022 | 26 | 2022 |
| Initial safety analysis of a randomized phase II trial of nelipepimut-S+ GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients … GT Clifton, KM Peace, JP Holmes, TJ Vreeland, DF Hale, GS Herbert, ... Clinical Immunology 201, 48-54, 2019 | 26 | 2019 |
